Misoprostol teratogenicity: A prospective study in Argentina;Efecto teratogénico del misoprostol: Un estudio prospectivo en Argentina

Archivos Argentinos de Pediatria

Volumn 109, Issue 3, 2011, Pages 226-231

  Barbero, Pablo ^a   Liascovich, Rosa ^a   Valdez, Rita ^b   Moresco, Angélica ^a  

^a Administracion Nacional de Laboratorios E Institutos de Salud Dr Carlos G Malbran   (Argentina)

^b FLENI   (Argentina)

Author keywords

Abortion; Congenital anomalies; Misoprostol; Teratogenic agents

Indexed keywords

MISOPROSTOL;

ABORTION; ARGENTINA; ARTICLE; COHORT ANALYSIS; CONGENITAL MALFORMATION; CYSTIC ADENOMATOID MALFORMATION; ENCEPHALOCELE; FEMALE; GESTATIONAL AGE; HUMAN; INTESTINE MALROTATION; LIMB DEFECT; PORENCEPHALY; PREGNANCY; PREGNANT WOMAN; PRENATAL DRUG EXPOSURE; PROGENY; PROSPECTIVE STUDY; TERATOGENICITY; ADULT; COMPARATIVE STUDY; CONTROLLED STUDY; LUNG MALFORMATION; PRESCRIPTION; PULMONARY ADENOMATOUS CYSTIC MALFORMATION;

ABNORMALITIES, DRUG-INDUCED; ABORTIFACIENT AGENTS, NONSTEROIDAL; ADULT; ARGENTINA; FEMALE; HUMANS; MISOPROSTOL; PREGNANCY; PROSPECTIVE STUDIES;

EID: 79958728195     PISSN: 03250075     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Allen R, O'Brien BM. Uses of misoprostol in obstetrics and gynecology. Rev Obstet Gynecol 2009;2:159-68.
2. Providing Medical Abortion in Low-resource Settings: An Introductory Guidebook, 2nd ed Abuabara, K., Blum, J. (eds. 1st edition), Bracken, H. (ed. 2nd edition), Gynuity Health Projects. [Acceso: 12 dic 2010]. Disponible en: http://gynuity.org/resources/info/medical-abortion-guidebook/.
3. Costa SH, Vessey MP. Misoprostol and illegal abortion in Rio de Janeiro, Brazil. Lancet 1993; 15, 341:1258-61. (Pubitemid 23146940)
4. Coelho HL, Teixeira AC, Santos Ap, Forte EB. Misoprostol and ilegal abortion in Fortaleza, Brazil. Lancet 1993;341:1261-3. (Pubitemid 23146941)
5. Faúndes A. Uso de misoprostol en obstetricia y ginecología. Federación Latinoamericana de Sociedades de Obstetricia y Ginecología, FLASOG. Santa Cruz: Industrias Gráficas Sirena; 2005.
6. Fernández MM, Coeytaux F, de León RG, Harrison DL. Assessing the global availability of misoprostol. Int J Gynaecol Obstet 2009;105(2):180-6.
7. Fonseca W, Alencar AJ, Mota FS, Coelho HL, et al. Misoprostol and congenital malformations. Lancet 1991;338:56.
8. Fonseca W, Alencar AJ, Pereira RM, Misago C. Congenital malformation of the scalp and cranium after failed first trimester abortion attempt with misoprostol. Clin Dysmorphol 1993;2:76-80. (Pubitemid 23112406)
9. González CH, Vargas FR, Pérez AB, Kim CA, et al. Limb deficiency with or without Mobius sequence in seven Brazilian children associated with misoprostol use in the first trimester of pregnancy. Am J Med Genet 1993;47:59-64. (Pubitemid 23221528)
10. González CH, Marques-Dias MJ, Kim CA, Sugayama SM, et al. Congenital abnormalities in Brazilian children associated with misoprostol misuse in 1st trimester of pregnancy. Lancet 1998;351:624-27.
11. Coelho KE, Sarmento MF, Veiga CM, Speck-Martins CE, et al. Misoprostol embryotoxicity: clinical evaluation of fifteen patients with arthrogryposis. Am J Med Genet 2000;95:297-301.
12. Pastuszak AL, Schüler-Faccin L, Speck-Martins CE, Coelho KE, et al. Use of misoprostol during pregnancy and Moebius syndrome in infants. New Engl J Med 1998;338:1881-5. (Pubitemid 28287860)
13. Orioli IM, Castilla EE. Epidemiological assessment of misoprostol teratogenicity. Br J Obstet Gynaecol 2000;107:519-23. (Pubitemid 30160543)
14. Vargas FR, Schuler-Faccini L, Brunoni D, Kim C, et al. Prenatal exposure to misoprostol and vascular disruption defects: a case-control study. Am J Med Genet 2000;95:302-6.
15. Schüler-Faccin L, Pastuszak A, Sanseverino TV, Orioli IM, et al. Pregnancy outcome after exposure to misoprostol in Brazil: a prospective controlled study. Reprod Toxicol 1999;13:147-51. (Pubitemid 29165846)
16. da Silva Dal Pizzol T, Tierling VL, Schüler-Faccin L, Sanseverino MT, et al. Reproductive results associated with misoprostol and other substances utilized for interruption of pregnancy. Eur J Clin Pharmacol 2005;61(1):71-2. (Pubitemid 40558285)
17. European Surveillance of Congenital Anomalies (EUROCAT) Minor Anomalies for Exclusión [Acceso: 12 de diciembre 2010]. Disponible en: http://www.eurocat-network.eu/content/EUROCAT-Guide-1.3-Chapter-3.2.pdf.
18. Stevenson R, Hall J, Goodman R. Human Malformations and Related Anomalies. Vol 2. Oxford Monographs on Medical Genetics N 27, pag 78-82, Oxford University Press.1993.
19. Moerman P, Fryns JP, Vandenberghe K, Devlieger H, Lauweryns JM. Pathogenesis of congenital cystic adenomatoid malformation of the lung. Histopathology 1992;21(4):315-21.
20. Philip N, Shannon C, Winikoff B. [Acceso: 1 noviembre 2010]. Disponible en: http://gynuity.org/downloads/misoprostol-teratogen-sp.pdf.
21. Cappon GD, Cook JC, Hurtt ME. Relationship between cyclooxygenase 1 and 2 selective inhibitors and fetal development when administered to rats and rabbits during the sensitive periods for heart development and midline closure. Birth Defects Res B Dev Reprod Toxicol 2003;68:47-56. (Pubitemid 37248103)
22. Ericson A, Kallen B. Nonsteroidal anti-inflammatory drugs in early pregnancy. Reprod Toxicol 2001;15:371-375. (Pubitemid 32758390)
23. Cleves MA, Savell VH Jr, Raj S, Zhao W, et al. Maternal use of acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), and muscular ventricular septal defects. Birth Defects Res A Clin Mol Teratol 2004;70:107-113. (Pubitemid 38524587)
24. Livshits A, Machtinger R, David LB, Spira M, et al. Ibuprofen and paracetamol for pain relief during medical abortion: a double-blind randomized controlled study. Fertil Steril 2009;91(5):1877-80.
25. Insua I, Romero M. Morbilidad materna severa en la Argentina, Egresos hospitalarios por aborto de establecimientos oficiales. [Acceso: 5 diciembre 2010]. Disponible en: www.cedes.org.ar/Publicaciones/RE/2007/6845.pdf.
26. Sedgh G, Henshaw S, Singh S, Ahman E, Shah IH. Induced abortion: estimated rates and trends worldwide. Lancet 2007;13,370(9595):1338-45. (Pubitemid 47539568)
27. Briozzo L, Vidiella G, Rodríguez F, Gorgoroso M, et al. A risk reduction strategy to prevent maternal deaths associated with unsafe abortion. Int J Gynaecol Obstet 2006;95(2):221-6. (Pubitemid 44635516)
28. Faúndes A, Rao K, Briozzo L. Right to protection from unsafe abortion and postabortion care. Int J Gynaecol Obstet 2009;106(2):164-7.
29. Vázquez S, Calandra N, Real P, Zingman F, et al. Un nuevo desafío en la atención de la adolescente consejería pre y postaborto. [Acceso: 20 diciembre 2010]. Disponible en: http://www.aaes.org.ar/ Publica/ArticulosPublicaciones/ae-ConPrePo.pdf.